Dutch and arctic mutant peptides of β amyloid1-40 differentially affect the FGF-2 pathway in brain endothelium

Experimental Cell Research

Volumn 315, Issue 3, 2009, Pages 385-395

  Solito, Raffaella ^a   Corti, Federico ^a   Fossati, Silvia ^b   Mezhericher, Emiliya ^b   Donnini, Sandra ^a   Ghiso, Jorge ^b   Giachetti, Antonio ^a   Rostagno, Agueda ^b   Ziche, Marina ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; A peptides; Cerebral amyloid angiopathy; Endothelial cells; FGF 2

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PEPTIDE DERIVATIVE;

AMINO ACID SUBSTITUTION; ARTICLE; BRAIN; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR AMYLOIDOSIS;

EID: 58149520137     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.11.002     Document Type: Article

References (41)

1. Renskin A.A.M., de Waal R.M.W., Kremer B., and Verbeek M.M. Pathogenesis of cerebral amyloid angiopathy. Brain Res. Rev. 43 (2003) 207-223
2. Vinters H.V. Cerebral amyloid angiopathy: a critical review. Stroke 18 (1987) 311-324
3. Revesz T., Ghiso J., Lashley T., Plant G., Rostagno A., Frangione B., and Holton J.L. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J. Neuropathol. Exp. Neurol. 62 (2003) 885-898
4. Maia L.F., Mackenzie I.R.A., and Feldman H.H. Clinical phenotypes of cerebral amyloid angiopathy. J. Neurol. Sci. 15 (2007) 23-30
5. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 1 (2000) 8-22
6. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., van Duinen S.G., Bots G.T.A.M., Luyendijk W., and Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral haemorrhage, Dutch type. Science 248 (1990) 1124-1126
7. Maat-Schieman M., Roos R., and Van Duinen S. Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neuropathology 25 (2005) 288-297
8. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B., Younkin S.G., Näslund J., and Lannfelt L. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4 (2001) 293-887
9. Wisniewski T., Ghiso J., and Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179 (1991) 1247-1254
10. Miravalle L., Tokuda T., Chiarle R., Giaccone G., Bugiani O., Tagliavini F., Frangione B., and Ghiso J. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275 (2000) 27110-27116
11. Paris D., Humphrey J., Quadros A., Patel N., Crescentini R., Crawford F., and Mullan M. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. Neurol. Res. 25 (2003) 642-651
12. Paris D., Townsend K., Quadros A., Humphrey J., Sun J., Brem S., Wotoczek-Obadia M., DelleDonne A., Pate N., Obregon D.F., Crescentini R., Abdullah L., Coppola D., Rojiani A.M., Crawford F., Sebti S.M., and Mullan M. Inhibition of angiogenesis by Ab peptides. Angiogenesis 7 (2004) 75-85
13. Donnini S., Cantara S., Morbidelli L., Giachetti A., and Ziche M. FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium. Cell Death Differ. 13 (2006) 1088-1096
14. Paris D., Aitghezala G., Mathura V.S., Patel N., Quadros A., Laporte V., and Mullan M. Anti-angiogenic activity of the mutant Dutch Aβ peptide on human brain microvascular endothelial cells. Mol. Brain Res. 136 (2005) 212-230
15. Ghiso J., Shayo M., Calero M., Ng D., Tomidokoro Y., Gandy S., Rostagno A., and Frangione B. Systemic catabolism of Alzheimer's Abeta40 and Abeta42. J. Biol. Chem. 279 (2004) 45897-45908
16. Kelly S.M., Jess T.J., and Price N.C. How to study proteins by circular dichroism. Biochem. Biophys. Acta 1751 (2005) 119-139
17. Walsh D.M., Hartley D.M., Kusumoto Y., Yezoui F., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., and Teplow D.B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274 (1999) 25945-25952
18. Levine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309 (1999) 274-284
19. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., and Rubin L.L. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell. Sci. 110 (1997) 1603-1613
20. Weksler B.B., Subileau E.A., Perriere N., Charmeau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turoski P., Male D.K., Rouix F., Greenwood J., Romeo I.A., and Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (2005) 1872-1874
21. Nehls V., and Drenckhahn D. A novel microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvas. Res. 50 (1995) 311-322
22. Cantara S., Donnini S., Morbidelli L., Giachetti A., Schulz R., Memo M., and Ziche M. Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2. FASEB J. 18 (2004) 1943-1945
23. Cam J., Meyerson J., Mezhericher E., Frangione B., Ghiso J., and Rostagno A. Differential apoptotic response of primary human cerebral endothelial cells to oligomeric assemblies of amyloid beta genetic variants. In: Fisher A., Hanin I., Poewe W., and Windisch M. (Eds). New Trends in Alzheimer and Parkinson Related Disorders (2008), Medimond International Proceedings, Bologna, Italy 141-146
24. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
25. Päiviö A., Jarvet J., Gräslund A., Lannfelt L., and Westlind-Danielsson A. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in Arctic mutant carriers. J. Mol. Biol. 339 (2004) 145-159
26. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., and Teplow D.B. Amyloid beta-protein fibrillogenesis: detection of a protofibrillar intermediate. J. Biol. Chem. 272 (1997) 22364-22372
27. Walsh D.M., and Selkoe D.J. Aβ oligomers - a decade of discovery. J. Neurochem. 101 (2007) 1172-1184
28. Whalen B.M., Selkoe D.J., and Hartley D.M. Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration. Neurobiol. Dis. 20 (2005) 254-266
29. Eisenhauer P.B., Johnson R.J., Wells J.M., Davies T.A., and Fine R.E. Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of Dutch-type mutant. J. Neurosci. Res. 60 (2000) 804-810
30. Mori H., Takio K., Ogawara M., and Selkoe D.J. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J. Biol. Chem. 267 (1992) 17082-17086
31. Miller D.L., Papayannopoulos I.A., Styles J., Bobin S.A., Lin Y.Y., Biemann K., and Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301 (1993) 41-52
32. Shin Y., Cho H.S., Fukumoto H., Shimizu T., Shirasawa T., Greenberg S.M., and Rebeck G.W. Abeta species, including IsoAsp23 Abeta, in Iowa-type familial cerebral amyloid angiopathy. Acta Neuropathol. 105 (2003) 252-258
33. Kumar-Singh S., Cras P., Wang R., Kros J.M., van Swieten J., Lübke U., Ceuterick C., Serneels S., Vennekens K., Timmermans J.P., Van Marck E., Martin J.J., van Duijn C.M., and Van Broeckhoven C. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am. J. Pathol. 161 (2002) 507-720
34. Zhang-Nunes S.X., Maat-Schieman M.L., van Duinen S.G., Roos R.A., Frosch M.P., and Greenberg S.M. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol. 16 (2006) 30-39
35. Prelli F., Levy E., van Duinen S.G., Bots G.T., Luyendijk W., and Frangione B. Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem. Biophys. Res. Commun. 170 (1990) 301-307
36. Castaño E.M., Prelli F., Soto C., Beavis R., Matsubara E., Shoji M., and Frangine B. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. J. Biol. Chem. 271 (1996) 32185-32191
37. Nishitsuji K., Tomiyama T., Ishibashi K., Kametani F., Ozawa K., Okada R., Maat-Schieman M.L., Roos R.A., Iwai K., and Mori H. Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type. J. Neurosci. Res. 85 (2007) 2917-2923
38. Morelli L., Llovera R., Gonzalez S.A., Affranchino J.L., Prelli F., Frangione B., Ghiso J., and Castaño E.M. Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J. Biol. Chem. 278 (2003) 23221-23226
39. Monro O.R., Mackic J.B., Yamada S., Segal M.B., Ghiso J., Maurer C., Calero M., Frangione B., and Zlokovic B.V. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging 23 (2002) 405-412
40. Davis J., Xu F., Miao J., Previti M.L., Romanov G., Ziegler K., and Van Nostrand W.E. Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice. Neurobiol. Aging 27 (2006) 946-954
41. Jung S.S., Zhang W., and Van Nostrand W.E. Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J. Neurochem. 85 (2003) 1208-1215